{
    "xml": "<topic id=\"PHP4671\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/ibandronic-acid\" basename=\"ibandronic-acid\" title=\"IBANDRONIC ACID\">\n<title>IBANDRONIC ACID</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_955\" namespace=\"/interactions/list-of-drug-interactions/bisphosphonates/ibandronic-acid\">Ibandronic Acid</xref>\n</p>\n<data name=\"vtmid\">395271007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_819087817\" title=\"Bisphosphonates\">Bisphosphonates</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34620\" title=\"BISPHOSPHONATES\" namespace=\"/drug-classes/bisphosphonates\">BISPHOSPHONATES</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP61647\" outputclass=\"indicationsAndDose\" rev=\"1.19\" parent=\"/drugs/ibandronic-acid\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Reduction in bone damage in bone metastases in breast cancer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8239;mg daily, alternatively (by intravenous infusion) 6&#8239;mg every 3&#8211;4&#8239;weeks.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypercalcaemia of malignancy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8211;4&#8239;mg as a single infusion, dose to be adjusted according to serum calcium concentration.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of postmenopausal osteoporosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult female\">\n<p>Adult (female)</p>\n<p>150&#8239;mg once a month, alternatively (by intravenous injection) 3&#8239;mg every 3&#8239;months, to be administered over 15&#8211;30&#8239;seconds.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61839\" outputclass=\"contraindications\" rev=\"1.10\" parent=\"/drugs/ibandronic-acid\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<title>General contraindications:</title>\n<p>\n<ph outputclass=\"contraindication\">Hypocalcaemia</ph>\n</p>\n<sectiondiv outputclass=\"additionalContraindications\">\n<p outputclass=\"title\">Specific contraindications:</p>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"contraindication\">abnormalities of the oesophagus</ph>; <ph outputclass=\"contraindication\">other factors which delay emptying (e.g. stricture or achalasia)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61889\" outputclass=\"cautions\" rev=\"1.7\" parent=\"/drugs/ibandronic-acid\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Atypical femoral fractures</ph>; <ph outputclass=\"caution\">cardiac disease (avoid fluid overload)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61622\" outputclass=\"interactions\" rev=\"1.6\" parent=\"/drugs/ibandronic-acid\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (bisphosphonates).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61516\" outputclass=\"sideEffects\" rev=\"1.11\" parent=\"/drugs/ibandronic-acid\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">asthenia</ph>; <ph outputclass=\"sideEffect\">bone pain</ph>; <ph outputclass=\"sideEffect\">chills</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">fever</ph>; <ph outputclass=\"sideEffect\">gastritis</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hypocalcaemia</ph>; <ph outputclass=\"sideEffect\">hypophosphataemia</ph>; <ph outputclass=\"sideEffect\">influenza-like symptoms</ph>; <ph outputclass=\"sideEffect\">muscle pain</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">pharyngitis</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaemia</ph>; <ph outputclass=\"sideEffect\">angioedema</ph>; <ph outputclass=\"sideEffect\">atypical femoral fractures</ph>; <ph outputclass=\"sideEffect\">bronchospasm</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">injection-site reactions</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Osteonecrosis of the jaw</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"sideEffect\">severe oesophageal reactions (discontinue)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61605\" outputclass=\"pregnancy\" parent=\"/drugs/ibandronic-acid\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61921\" outputclass=\"breastFeeding\" parent=\"/drugs/ibandronic-acid\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;present in milk in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61549\" outputclass=\"renalImpairment\" parent=\"/drugs/ibandronic-acid\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>When used for bone metastases, if eGFR 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup> reduce dose to 4&#8239;mg and infuse over 1 hour; if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup> reduce dose to 2&#8239;mg and infuse over 1 hour.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>When used for bone metastases, if eGFR 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup> reduce dose to 50&#8239;mg on alternative days; if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup> reduce dose to 50&#8239;mg once weekly.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>When used for postmenopausal osteoporosis, avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61497\" outputclass=\"monitoringRequirements\" parent=\"/drugs/ibandronic-acid\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor renal function and serum calcium, phosphate and magnesium.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61979\" outputclass=\"directionsForAdministration\" rev=\"1.10\" parent=\"/drugs/ibandronic-acid\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Tablets should be swallowed whole with plenty of water while sitting or standing; to be taken on an empty stomach at least 30 minutes (for most ibandronic acid tablets, 50&#8239;mg) or 1 hour (for <i>Bonviva </i>\n<tm tmtype=\"reg\"/> tablets, 150&#8239;mg) before first food or drink (other than water) of the day, or another oral medicine; patient should stand or sit upright for at least 1 hour after taking tablet.</p>\n</sectiondiv>\n<sectiondiv>\n<p>For <i>intravenous infusion</i> (<i>Bondronat</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5% or Sodium chloride 0.9%; dilute requisite dose in 500&#8239;mL infusion fluid and give over 1&#8211;2 hours.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61576\" outputclass=\"patientAndCarerAdvice\" rev=\"1.24\" parent=\"/drugs/ibandronic-acid\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"patientResources\">\n<sectiondiv>\n<p>A patient reminder card should be provided to patients receiving intravenous ibandronic acid (risk of osteonecrosis of the jaw).</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be given advice on how to administer ibandronic acid tablets.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Oesophageal reactions</p>\n<p>Patients and carers should be advised to stop tablets and seek medical attention for symptoms of oesophageal irritation such as dysphagia, pain on swallowing, retrosternal pain, or heartburn.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4671-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/ibandronic-acid\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74974\" title=\"Tablet\" namespace=\"/drugs/ibandronic-acid/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74981\" title=\"Solution for injection\" namespace=\"/drugs/ibandronic-acid/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74987\" title=\"Solution for infusion\" namespace=\"/drugs/ibandronic-acid/solution-for-infusion\">Solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_955\" namespace=\"/interactions/list-of-drug-interactions/bisphosphonates/ibandronic-acid\" title=\"Ibandronic Acid\" count=\"1\" rel=\"link\">Ibandronic Acid</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34620\" namespace=\"/drug-classes/bisphosphonates\" title=\"BISPHOSPHONATES\" count=\"1\" rel=\"link\">BISPHOSPHONATES</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74974\" namespace=\"/drugs/ibandronic-acid/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74981\" namespace=\"/drugs/ibandronic-acid/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74987\" namespace=\"/drugs/ibandronic-acid/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP4671",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/ibandronic-acid",
    "basename": "ibandronic-acid",
    "title": "IBANDRONIC ACID",
    "interactants": [
        {
            "id": "bnf_int_955",
            "label": "Ibandronic Acid"
        }
    ],
    "vtmid": "395271007",
    "drugClassification": [
        "Bisphosphonates"
    ],
    "inheritsFromClass": [
        "BISPHOSPHONATES"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Reduction in bone damage in bone metastases in breast cancer",
                        "html": "Reduction in bone damage in bone metastases in breast cancer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially mouth"
                    ],
                    "textContent": "Initially by mouth",
                    "html": "Initially by mouth"
                },
                "adult": [
                    {
                        "textContent": "50 mg daily, alternatively (by intravenous infusion) 6 mg every 3&#8211;4 weeks.",
                        "html": "<p>50&#8239;mg daily, alternatively (by intravenous infusion) 6&#8239;mg every 3&#8211;4&#8239;weeks.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Hypercalcaemia of malignancy",
                        "html": "Hypercalcaemia of malignancy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "2&#8211;4 mg as a single infusion, dose to be adjusted according to serum calcium concentration.",
                        "html": "<p>2&#8211;4&#8239;mg as a single infusion, dose to be adjusted according to serum calcium concentration.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of postmenopausal osteoporosis",
                        "html": "Treatment of postmenopausal osteoporosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially mouth"
                    ],
                    "textContent": "Initially by mouth",
                    "html": "Initially by mouth"
                },
                "adult female": [
                    {
                        "textContent": "150 mg once a month, alternatively (by intravenous injection) 3 mg every 3 months, to be administered over 15&#8211;30 seconds.",
                        "html": "<p>150&#8239;mg once a month, alternatively (by intravenous injection) 3&#8239;mg every 3&#8239;months, to be administered over 15&#8211;30&#8239;seconds.</p>",
                        "ageGroup": "adult (female)"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Hypocalcaemia",
                "html": "Hypocalcaemia"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "abnormalities of the oesophagus",
                "html": "abnormalities of the oesophagus",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "other factors which delay emptying (e.g. stricture or achalasia)",
                "html": "other factors which delay emptying (e.g. stricture or achalasia)",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Atypical femoral fractures",
                "html": "Atypical femoral fractures"
            },
            {
                "type": "cautions",
                "textContent": "cardiac disease (avoid fluid overload)",
                "html": "cardiac disease (avoid fluid overload)"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (bisphosphonates).",
                "html": "<p>Appendix 1 (bisphosphonates).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "asthenia",
                        "html": "asthenia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "bone pain",
                        "html": "bone pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "chills",
                        "html": "chills",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "fever",
                        "html": "fever",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "gastritis",
                        "html": "gastritis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypocalcaemia",
                        "html": "hypocalcaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypophosphataemia",
                        "html": "hypophosphataemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "influenza-like symptoms",
                        "html": "influenza-like symptoms",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "muscle pain",
                        "html": "muscle pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pharyngitis",
                        "html": "pharyngitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Anaemia",
                        "html": "Anaemia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "angioedema",
                        "html": "angioedema",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "atypical femoral fractures",
                        "html": "atypical femoral fractures",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "bronchospasm",
                        "html": "bronchospasm",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "injection-site reactions",
                        "html": "injection-site reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Osteonecrosis of the jaw",
                        "html": "Osteonecrosis of the jaw",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "severe oesophageal reactions (discontinue)",
                        "html": "severe oesophageal reactions (discontinue)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid.",
                "html": "<p>Avoid.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;present in milk in animal studies.",
                "html": "<p>Avoid&#8212;present in milk in <i>animal</i> studies.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "When used for bone metastases, if eGFR 30&#8211;50 mL/minute/1.73 m2 reduce dose to 4 mg and infuse over 1 hour; if eGFR less than 30 mL/minute/1.73 m2 reduce dose to 2 mg and infuse over 1 hour.",
                "html": "<p>When used for bone metastases, if eGFR 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup> reduce dose to 4&#8239;mg and infuse over 1 hour; if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup> reduce dose to 2&#8239;mg and infuse over 1 hour.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "When used for bone metastases, if eGFR 30&#8211;50 mL/minute/1.73 m2 reduce dose to 50 mg on alternative days; if eGFR less than 30 mL/minute/1.73 m2 reduce dose to 50 mg once weekly.",
                "html": "<p>When used for bone metastases, if eGFR 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup> reduce dose to 50&#8239;mg on alternative days; if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup> reduce dose to 50&#8239;mg once weekly.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "When used for postmenopausal osteoporosis, avoid if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>When used for postmenopausal osteoporosis, avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor renal function and serum calcium, phosphate and magnesium.",
                "html": "<p>Monitor renal function and serum calcium, phosphate and magnesium.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Tablets should be swallowed whole with plenty of water while sitting or standing; to be taken on an empty stomach at least 30 minutes (for most ibandronic acid tablets, 50 mg) or 1 hour (for Bonviva tablets, 150 mg) before first food or drink (other than water) of the day, or another oral medicine; patient should stand or sit upright for at least 1 hour after taking tablet.",
                "html": "<p>Tablets should be swallowed whole with plenty of water while sitting or standing; to be taken on an empty stomach at least 30 minutes (for most ibandronic acid tablets, 50&#8239;mg) or 1 hour (for <i>Bonviva </i>\n<tm tmtype=\"reg\"/> tablets, 150&#8239;mg) before first food or drink (other than water) of the day, or another oral medicine; patient should stand or sit upright for at least 1 hour after taking tablet.</p>"
            },
            {
                "type": "directionsForAdministration",
                "textContent": "For intravenous infusion (Bondronat ), give intermittently in Glucose 5% or Sodium chloride 0.9%; dilute requisite dose in 500 mL infusion fluid and give over 1&#8211;2 hours.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Bondronat</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5% or Sodium chloride 0.9%; dilute requisite dose in 500&#8239;mL infusion fluid and give over 1&#8211;2 hours.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "textContent": "A patient reminder card should be provided to patients receiving intravenous ibandronic acid (risk of osteonecrosis of the jaw).",
                "html": "<p>A patient reminder card should be provided to patients receiving intravenous ibandronic acid (risk of osteonecrosis of the jaw).</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be given advice on how to administer ibandronic acid tablets.",
                "html": "<p>Patients or carers should be given advice on how to administer ibandronic acid tablets.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "title": "Oesophageal reactions",
                "textContent": "Patients and carers should be advised to stop tablets and seek medical attention for symptoms of oesophageal irritation such as dysphagia, pain on swallowing, retrosternal pain, or heartburn.",
                "html": "<p>Patients and carers should be advised to stop tablets and seek medical attention for symptoms of oesophageal irritation such as dysphagia, pain on swallowing, retrosternal pain, or heartburn.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74974",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74981",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74987",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_955",
                "label": "Ibandronic Acid",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34620",
                "label": "BISPHOSPHONATES",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74974",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74981",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74987",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}